Related Experiment Videos
Superoxide dismutases in human palatine tonsils
M T Lai1, T Ohmichi, S Miyahara
1Department of Otolaryngology, Okayama University Medical School, Japan.
Acta Oto-Laryngologica. Supplementum
|January 1, 1996
Summary
Human palatine tonsils protect against damaging superoxide radicals using superoxide dismutases (SODs). SOD activity and distribution in tonsils are not significantly affected by systemic diseases.
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- Human palatine tonsils possess a bactericidal system generating cytotoxic superoxide radicals (O(-)(2)).
- Superoxide dismutases (SODs) are crucial enzymes that neutralize superoxide radicals.
- Understanding SODs' role in tonsils is vital for immune defense mechanisms.
Purpose of the Study:
- To investigate the distribution and activity of SODs in human palatine tonsils.
- To assess the impact of systemic diseases on tonsillar SODs.
- To elucidate the protective role of SODs against superoxide radicals in tonsils.
Main Methods:
- Immunohistochemistry was employed to determine SOD distribution within tonsillar tissues.
- Electron spin resonance (ESR) spectrometry was utilized to quantify SOD activity.
- Tonsils from patients with different systemic diseases were analyzed.
Main Results:
- SODs were predominantly found in the extrafollicular lymphatic tissue and crypt epithelium.
- No significant differences in SOD distribution or activity were observed between tonsils from patients with different systemic diseases.
- Mitochondrial SOD activity accounted for approximately 50%-60% of the total cellular SOD activity in tonsils.
Conclusions:
- Human palatine tonsils possess an intrinsic defense system against cytotoxic superoxide radicals.
- The crypt epithelium and extrafollicular lymphatic tissue may be primary sites of superoxide radical exposure.
- SODs play a significant role in protecting tonsillar germinal centers from oxidative injury.
- Local SOD expression in tonsils appears largely independent of systemic disease status.